Nutritional status of renal transplant patients

South African Medical Journal

Volumn 92, Issue 1, 2002, Pages 68-74

  du Plessis, A S ^a   Randall, H ^a   Escreet, E ^a   Holl M ^a   Conradie, M ^a   Moosa, M R ^a   Labadarios, D ^a   Herselman, M G ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; AZATHIOPRINE; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MAGNESIUM; PYRIDOXINE; SERUM ALBUMIN;

ADULT; ANTHROPOMETRY; ARTICLE; ASCORBIC ACID DEFICIENCY; BIOCHEMISTRY; BODY MASS; CLINICAL EXAMINATION; CONTROLLED STUDY; DIET; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PYRIDOXINE DEFICIENCY; SAMPLE; SOUTH AFRICA; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

ADULT; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; DIET; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NUTRITION DISORDERS; NUTRITIONAL STATUS; PILOT PROJECTS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036159076     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Methods for assessing status of patients with renal failure
2. Nutrition in renal failure
3. Causes of catabolism and wasting in acute or chronic renal failure
4. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study
5. Skeletal muscle function in chronic renal failure. An index of nutritional status
6. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure
7. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes
8. Nutritional state in patients on long-term low-protein diet or with nephrotic syndrome
9. Trace elements and vitamins in renal disease
10. Calcium, phosphorous, and vitamin D
11. Lipid abnormalities in uremia, dialysis and transplantation
12. Lipid abnormalities in renal disease
13. Hyperlipidemia in stable renal transplant recipients
14. Metabolic and endocrine complications in transplantation
15. Factors influencing weight gain after renal transplantation
16. Nutritional requirements of renal transplant patients
17. Race and diabetes as death risk predictors in hemodialysis patients
18. Protein-energy malnutrition as a risk factor for morbidity in haemodialysis patients
19. Underweight rather than overweight predicts death in hemodialysis population
20. Serum albumin and mortality after renal transplantation
21. Prediction of reduction in predialysis concentration due to interdialysis weight gain
22. Persistent hyperlipidemia in renal transplant patients
23. Impact of serum lipids on long term graft and patient survival after renal transplantation
24. Lipid abnormalities in cyclosporine-treated renal transplant recipients
25. Origin and pattern of glucocorticoid-induced hyperlipidemia in rates. Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity
26. Cyclosporine versus azathioprine: Review of 200 consecutive cadaver renal transplant recipients
27. Hyperlipidemia and glucose intolerance in the post-renal transplant patient
28. Sequential changes of biochemical bone parameters after kidney transplantation
29. Magnesium deficiency: Pathophysiologic and clinical overview
30. Nutritional status, muscle composition and plasma and muscle free amino acids in renal transplant patients
31. Clinical and laboratory observations: Pathogenesis of cyclosporine-induced hypomagnesemia
32. Pyridoxal 5′-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients
33. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients
34. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia
35. Treatment of hyperhomocysteinemia in renal transplant patients. A randomized, placebo-controlled trial
36. Prospective study of coronary heart disease incidence in relation to fasting homocysteine, related genetic polymorphisms, and B vitamins. The atherosclerosis risk in communities (ARIC) study
37. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance
38. Altered body fat distribution in patients with glucocorticoid treatment and in patient on long-term dialysis
39. New variables reported to the UNOS Registry and their impact on cadaveric renal transplant outcomes: A preliminary study
40. Is obesity still a risk factor in renal transplantation?
41. The impact of pre-transplant obesity on renal transplant outcomes
42. Should obese patients lose weight before receiving a kidney transplant?
43. Nutritional status of diabetic and nondiabetic patients after renal transplantation
44. Altered skeletal muscle ultrastructure in renal transplant patients on prednisone